Recruiting studies: Hepatobiliary Cancers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients
Phase N/A · 1 location(s) · Methodist Health System · NCT07644091 Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
NA · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06126419 Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02361320 Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NA · 13 location(s) · European Organisation for Research and Treatment of Cancer - · NCT04498767 Social Determinants of Health in Hepatobiliary Cancer Patients
Phase N/A · 1 location(s) · Mayo Clinic · NCT06053333 The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06597539 D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Phase N/A · 1 location(s) · Fujian Provincial Hospital · NCT06643208 Observational Study Protocol: LIVER-R
Phase N/A · 159 location(s) · AstraZeneca · NCT06252753 Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
Phase N/A · 1 location(s) · Tongji Hospital · NCT05520788 SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre
Phase 2 · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT07174947 High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NA · 1 location(s) · Algemeen Ziekenhuis Maria Middelares · NCT06835426 Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
NA · 1 location(s) · University of California, Irvine · NCT05497531 Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancer
NA · 1 location(s) · Mayo Clinic · NCT07124546 Prediction Model for MINS After Major Hepatobiliary Surgery
Phase N/A · 6 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07335042 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881 Targeted Navigation in Hepatocellular Carcinoma (HCC)
NA · 1 location(s) · University of Miami · NCT06260943 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069 Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781242 Ligufalimab and Cadonilimab in Advanced Liver Cancers
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT06789848 A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT05098197 Effect and Mechanism of ALPPS Operation on Liver Regeneration
Phase N/A · 1 location(s) · Haitao Zhao, MD · NCT07142213 Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
Phase N/A · 5 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06777914

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.